LSB Industries heads into its May 21 Q1 print with a notable insider-selling backdrop that contrasts sharply with a string of upward analyst revisions.
The insider story is hard to ignore. The most significant move came in late March, when majority stakeholder Todd Boehly sold nearly 4.9 million shares at $14.85 — a $72.6 million disposal that slashed his reported holding. CEO Mark Behrman sold 250,000 shares at $11.75 in early March, and CFO Cheryl Maguire trimmed 20,000 shares at $15.00 later that month. Net insider selling over the 90 days through late March totalled roughly $78.3 million in value. Insiders were selling into what was then a recovering share price — the stock has since pulled back 11% on the week to $13.71.
The analyst picture tells a different story. Coverage has been broadly constructive through the year, with RBC Capital and UBS repeatedly lifting targets. RBC downgraded to Sector Perform in early April while simultaneously raising its target to $14, then nudged it further to $15 on May 11. UBS trimmed its target modestly to $16 on May 13 while holding Neutral. The mean target across the Street sits near $15 — modest upside from current levels, but not a dramatic gap. The bull case centres on elevated nitrogen prices, operational cost improvements, and the longer-term optionality around blue ammonia production at the El Dorado facility. Bears point to the three variables that make LXU inherently difficult to model: natural gas input costs, weather-driven fertilizer demand, and the persistent overhang from Eldridge Industries as the majority shareholder.
EPS momentum reinforces the bull case in the data. The company ranks in the 98th percentile on 90-day EPS momentum and the 90th percentile on EPS surprise — a signal that recent estimates have been moving in the right direction and that the company has been delivering above expectations. EV/EBITDA is running near 5.9x, a reasonable multiple for a nitrogen producer with free cash flow of roughly $107 million on an annualised basis.
Short positioning offers no signal worth leaning on. Short interest at 2% of the free float is low, with availability in the lending pool at an extremely loose 3,850% — there are roughly 38 shares available to borrow for every one currently shorted. Borrowing costs have eased to around 0.52% from over 2% in early April. Options positioning is similarly muted; the put/call ratio is barely above its 20-day average, with a z-score near zero. The market is not visibly hedging into this print. Peers including CF and IPI drifted lower on the week, though CF held relatively flat.
The print will test whether the company's EPS momentum can survive the combination of a recent stock slide, aggressive insider selling at higher prices, and a Street that has shifted from outright bullish to cautiously neutral — all while nitrogen market conditions remain the single variable no model can reliably pin down.
See the live data behind this article on ORTEX.
Open LXU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
